LAURA SHEEDY: Open Payments
NPI 1962821850 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 75 payments from 18 companies in 2025. Trend: 2023 $1,604 · 2024 $2,140 · 2025 $1,705
Food & beverage: $1,515Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $325 |
| Novartis Pharmaceuticals Corporation | 12 | $300 |
| ABBVIE INC. | 17 | $259 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $121 |
| Arcutis Biotherapeutics, Inc. | 4 | $96 |
| Lilly USA, LLC | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| GENZYME CORPORATION | 2 | $67 |
| Incyte Corporation | 3 | $64 |
| UCB, Inc. | 2 | $59 |
Products named: TREMFYA, COSENTYX, DUPIXENT, Zoryve, SKYRIZI, RINVOQ, OPZELURA, EBGLYSS.
Industry payments across TX — which companies pay providers there.
